12月4日恒生指数上涨0.68%，南向资金全天合计成交金额为756.88亿港元，其中，买入成交385.84亿港 元，卖出成交371.04亿港元，合计净买入金额14.80亿港元。具体来看，港股通（深）累计成交金额 293.41亿港元，买入成交159.11亿港元，卖出成交134.30亿港元，合计净买入金额24.81亿港元；港股通 （沪）累计成交金额463.47亿港元，买入成交226.73亿港元，卖出成交236.74亿港元，合计净卖出金额 10.00亿港元。 12月4日南向资金成交活跃股 | 代码 | 简称 | 成交金额（万港元） | 成交净买入（万港元） | 今日涨跌幅（%） | | --- | --- | --- | --- | --- | | 02800 | 盈富基金 | 284623.16 | 260585.86 | 0.77 | | 02269 | 药明生物 | 51978.36 | 31558.31 | 7.09 | | 01810 | 小米集团-W | 499493.94 | 23169.32 | 4.38 | | 09868 | 小鹏汽车-W | 73564.27 | 10257.11 | 1.06 ...

Core Insights - On December 4, 2025, Tencent Holdings (00700), Alibaba-W (09988), and Xiaomi Group-W (01810) were the top three companies by trading volume in the southbound trading of the Stock Connect, with trading amounts of 3.75 billion, 2.939 billion, and 2.678 billion respectively [1] - In the southbound trading of the Shenzhen-Hong Kong Stock Connect, Alibaba-W (09988), Xiaomi Group-W (01810), and Tencent Holdings (00700) also ranked as the top three, with trading amounts of 2.379 billion, 2.316 billion, and 1.521 billion respectively [1] Southbound Trading Highlights - **Top Active Companies in Southbound Trading (Hong Kong Stock Connect)** - Tencent Holdings (00700): Trading amount of 3.75 billion, net buy of -1.919 billion - Alibaba-W (09988): Trading amount of 2.939 billion, net buy of -70.44 million - Xiaomi Group-W (01810): Trading amount of 2.678 billion, net buy of -562 million - Other notable companies include Yingfu Fund (02800) with a trading amount of 2.342 billion and a net buy of 2.107 billion [2] - **Top Active Companies in Southbound Trading (Shenzhen-Hong Kong Stock Connect)** - Alibaba-W (09988): Trading amount of 2.379 billion, net buy of 69.27 million - Xiaomi Group-W (01810): Trading amount of 2.316 billion, net buy of 794 million - Tencent Holdings (00700): Trading amount of 1.521 billion, net buy of 573 million - Other notable companies include SMIC (00981) with a trading amount of 1.07 billion and a net buy of -79.37 million [2]

Summary of Key Points Core Viewpoint - The Hong Kong stock market experienced significant net inflows from northbound trading, with a total net buy of 14.8 billion HKD on December 4, 2023, indicating strong investor interest in certain stocks while others faced net selling pressure [1]. Group 1: Stock Performance - The top net bought stocks included 盈富基金 (02800) with a net buy of 26.05 billion HKD, 药明生物 (02269) with a net buy of 3.15 billion HKD, and 小米集团-W (01810) with a net buy of 2.31 billion HKD [4][5]. - The stocks with the highest net selling included 腾讯 (00700) with a net sell of 13.45 billion HKD, 中芯国际 (00981) with a net sell of 4.58 billion HKD, and 三花智控 (02050) with a net sell of 5657.75 million HKD [5][6]. Group 2: Market Insights - 中金公司 suggests that the upcoming US-China meetings may support risk assets, recommending an overweight position in Chinese stocks ahead of the meetings [4]. - 浦银国际 expresses optimism for the CXO sector by 2026, citing potential growth in overseas biopharmaceutical financing due to anticipated interest rate cuts [4]. - The semiconductor industry shows divergence, with 华虹半导体 (01347) receiving a net buy of 5363 million HKD, while 中芯国际 (00981) faced significant net selling [5]. Group 3: Company Developments - 小米集团's president announced significant investments in AI, indicating progress beyond expectations in AI models and applications [5]. - 优必选 (09880) signed a strategic cooperation agreement with 卓世科技, aiming for the deployment of 10,000 robots over the next five years [6]. - 中海油 (00883) reported the production commencement of a new oil field project, expecting peak production of approximately 16,900 barrels of oil equivalent per day by 2026 [5].

午后市场情绪回升，港股三大指数再度冲高，恒生科技指数一度涨至2%，最终收涨1.45%重回5600点上方，恒生指数涨0.68%报25935点，国企指数涨0.86% 报9106点。 | 代码 | 名称 | | 最新价 | 涨跌额 | 涨跌幅 | | --- | --- | --- | --- | --- | --- | | 800000 | 恒生指数 | @ | 25935.90 | +175.17 | 0.68% | | 800100 | 国正指数 | | 9106.48 | +77.93 | 0.86% | | 800700 | 恒生科技指数 | | 5615.43 | +80.51 | 1.45% | | 行业热力图 ▼ | 领涨板块 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 汽车 | 地产发展商 | 药品 +1.18% | 服装 +0.50% | 互动 + | | | 银行 +0.74% | 线上零售商 +0.74% | 电讯服务 +0.02% | +0.56% | +0.14% | ...

Market Overview - The Hong Kong stock market showed a rebound in sentiment, with the Hang Seng Technology Index rising by 1.45% to above 5600 points, while the Hang Seng Index increased by 0.68% to 25935 points, and the National Enterprises Index rose by 0.86% to 9106 points [1][2]. Sector Performance - Large technology stocks collectively rose, with notable gains from Xiaomi (over 4%) and Meituan (over 2%). The pharmaceutical sector saw a surge, with orders for flu treatment drugs increasing nearly ninefold, leading to strong performance in related stocks [2][4]. - The semiconductor sector was active, with companies like Cambrian aiming to triple chip production, and stocks such as Horizon Robotics and SMIC also showing significant gains [2][9]. - The biopharmaceutical sector experienced substantial growth, with WuXi AppTec rising over 9% and other related stocks also performing well due to increased demand for flu medications [6]. - The robotics sector was strong, with companies like Cloudwalk and Horizon Robotics seeing gains of over 7% [7]. - The entertainment sector showed positive movement, with Lemon Films rising over 5% amid a strong box office performance during the holiday season [11]. Individual Stock Movements - Notable individual stock performances included: - Horizon Robotics: +6.97% [5] - Xiaomi Group: +4.38% [5] - WuXi AppTec: +9.09% [6] - Cloudwalk: +8.67% [8] - Conversely, the restaurant sector faced declines, with Shanghai Xiaonan falling over 4% [13]. Capital Flows - Southbound funds recorded a net inflow of 1.48 billion HKD, with the Hong Kong Stock Connect (Shanghai) showing a net sell of 1 billion HKD and the Hong Kong Stock Connect (Shenzhen) showing a net buy of 2.481 billion HKD [19]. Future Outlook - Analysts predict that the Hong Kong stock market may experience fluctuations, with the Hang Seng Index expected to range between 23500 and 30500 points in 2026. Recommendations include buying on dips and focusing on sectors such as technology, high-end manufacturing, and renewable energy [21].

交银国际发布研报称，2025年CXO整体订单和业绩复苏势头明显。我们预计，随着下游融资边际改善 +出海热潮带动上游景气度逐步进一步回升，2026年板块有望维持较快的业绩增速，但在美国药品相关 监管收紧、新药研发难度升级的长期大趋势下，行业整合或才刚拉开序幕，未来将继续淘汰落后产能及 企业。因此，我们认为高景气度赛道中的头部玩家有较高的长期确定性。 本文源自：智通财经网 智通财经获悉，CRO概念股午后快速拉升，截至发稿，药明生物(02269)涨4.94%，报32.28港元；金斯 瑞生物科技(01548)涨3.8%，报15.01港元；药明康德(02359)涨2.62%，报99.95港元；泰格医药(03347)涨 1.22%，报38.04港元。 消息面上，药明生物12月2日宣布，已与卡塔尔自由区管理局（QFZ）签署战略合作备忘录，将全球服 务网络与专业业务能力拓展至中东地区。此次战略合作为药明生物在卡塔尔自由区打造其在中东地区首 个一体化CRDMO中心奠定了基础。 ...

Core Viewpoint - The Hong Kong stock market's innovative drug concept stocks are experiencing a continuous rebound, with notable increases in share prices for several companies [1] Group 1: Company Performance - Gilead Sciences-B has seen a rise of over 9% [1] - WuXi Biologics has increased by more than 6% [1] - Other companies such as Rongchang Biopharmaceutical, Innovent Biologics, and I-Mab have also shown upward movement in their stock prices [1]

Group 1 - CRO concept stocks experienced a rapid increase in afternoon trading, with WuXi Biologics (02269) rising by 4.94% to HKD 32.28, Kintor Pharmaceutical (01548) up by 3.8% to HKD 15.01, WuXi AppTec (603259) (02359) increasing by 2.62% to HKD 99.95, and Tigermed (300347) (03347) gaining 1.22% to HKD 38.04 [1] - WuXi Biologics announced a strategic cooperation memorandum with Qatar Free Zones Authority (QFZ) on December 2, aiming to expand its global service network and professional capabilities into the Middle East, establishing its first integrated CRDMO center in the Qatar Free Zone [1] - According to a report from CMB International, the overall orders and performance of the CXO sector are expected to recover significantly by 2025, driven by marginal improvements in downstream financing and an export boom, with the sector likely to maintain rapid performance growth in 2026 [1] Group 2 - The report highlights that despite the positive outlook, the industry may face challenges due to tightening drug-related regulations in the U.S. and increasing difficulties in new drug development, suggesting that industry consolidation may just be beginning [1] - The report emphasizes that leading players in high-growth sectors have a higher long-term certainty, as the industry continues to eliminate outdated capacity and companies [1]

消息面上，药明生物12月2日宣布，已与卡塔尔自由区管理局（QFZ）签署战略合作备忘录，将全球服 务网络与专业业务能力拓展至中东地区。此次战略合作为药明生物在卡塔尔自由区打造其在中东地区首 个一体化CRDMO中心奠定了基础。 交银国际发布研报称，2025年CXO整体订单和业绩复苏势头明显。我们预计，随着下游融资边际改善 +出海热潮带动上游景气度逐步进一步回升，2026年板块有望维持较快的业绩增速，但在美国药品相关 监管收紧、新药研发难度升级的长期大趋势下，行业整合或才刚拉开序幕，未来将继续淘汰落后产能及 企业。因此，我们认为高景气度赛道中的头部玩家有较高的长期确定性。 智通财经APP获悉，CRO概念股午后快速拉升，截至发稿，药明生物(02269)涨4.94%，报32.28港元；金 斯瑞生物科技(01548)涨3.8%，报15.01港元；药明康德(02359)涨2.62%，报99.95港元；泰格医药(03347) 涨1.22%，报38.04港元。 ...

Core Viewpoint - The Hong Kong stock market is experiencing a pullback, but there is a counter-trend inflow of funds, particularly into the Hong Kong Technology ETF (159751), which saw a net subscription of 10 million units. The market is expected to continue its upward trend due to strong overall profitability and the scarcity of assets in sectors like the internet, new consumption, and innovative pharmaceuticals, alongside the anticipated interest rate cut by the Federal Reserve in December [1]. Group 1 - The Hong Kong Technology ETF (159751) closely tracks the CSI Hong Kong Stock Connect Technology Index, which selects 50 large-cap, high R&D investment, and high revenue growth technology companies to reflect the overall performance of technology leaders in the Hong Kong Stock Connect [1]. - As of December 3, 2025, the CSI Hong Kong Stock Connect Technology Index (931573) shows mixed performance among its constituent stocks, with Huahong Semiconductor (01347) leading with a 2.40% increase, followed by Gao Wei Electronics (01415) at 1.81%, and BYD Electronics (00285) at 1.28% [1]. - The overall valuation of the Hong Kong stock market remains low despite several months of increases, indicating a high long-term allocation cost-performance ratio [1]. Group 2 - As of November 28, 2025, the top ten weighted stocks in the CSI Hong Kong Stock Connect Technology Index (931573) include Alibaba-W (09988), Tencent Holdings (00700), and SMIC (00981), with these ten stocks accounting for 67.26% of the index [2].